Authors: HENRIKSSON R NILSSON S COLLEEN S WERSALL P HELSING M ZIMMERMAN R ENGMAN K

Citation: R. Henriksson et al., SURVIVAL IN RENAL-CELL CARCINOMA - A RANDOMIZED EVALUATION OF TAMOXIFEN VS INTERLEUKIN-2, ALPHA-INTERFERON (LEUKOCYTE) AND TAMOXIFEN, British Journal of Cancer, 77(8), 1998, pp. 1311-1317

Authors: HENRIKSSON R NILSSON S COLLEEN S WERSALL P HELSING M ZIMMERMAN R ENGMAN K

Citation: R. Henriksson et al., SURVIVAL IN RENAL-CELL CARCINOMA (RCC) - A RANDOMIZED EVALUATION OF TAMOXIFEN VERSUS INTERLEUKIN-2, ALPHA-INTERFERON (LEUKOCYTE) AND TAMOXIFEN, European journal of cancer, 33, 1997, pp. 152-152

Authors: BRACONIER JH PAULSEN O ENGMAN K WIDELL A

Citation: Jh. Braconier et al., COMBINED ALPHA-INTERFERON AND RIBAVIRIN TREATMENT IN CHRONIC HEPATITIS-C - A PILOT-STUDY, Scandinavian journal of infectious diseases, 27(4), 1995, pp. 325-329

Authors: MERUP M TORNEBOHMROCHE E ENGMAN K PAUL C

Citation: M. Merup et al., HUMAN-LEUKOCYTE INTERFERON-ALPHA THERAPY CAN INDUCE A 2ND RESPONSE INTREATMENT OF THROMBOCYTOSIS IN PATIENTS WITH NEUTRALIZING ANTIBODIES TO RECOMBINANT INTERFERON-ALPHA-2A, European journal of cancer, 30A(11), 1994, pp. 1729-1730

Authors: MERUP M ENGMAN K PAUL C

Citation: M. Merup et al., INTERFERON ANTIBODIES IN THROMBOCYTHEMIA, Journal of interferon research, 14(4), 1994, pp. 187-189